Synergistically therapeutic effects of VEGF165 and angiopoietin-1 on ischemic rat myocardium.

Xiang Liu,Yijiang Chen,Fumin Zhang,Lizhen Chen,Tuanzhu Ha,Xiang Gao,Chuanfu Li
DOI: https://doi.org/10.1080/14017430701197593
2009-01-01
Scandinavian Cardiovascular Journal
Abstract:Purpose. The aim of this study was to determine whether the combination of 2 angiogenic growth factor, vascular endothelial growth factor 165(VEGF165) and angiopoietin-1 (Ang1), could increase angiogenesis and cardiomyocyte(CM) proliferation in an infarcted myocardium. Methods. Myocardial ischemia was induced in rats by ligation of the left anterior descending (LAD) coronary artery. Replication-deficient adenoviruses encoding VEGF165 (Ad-VEGF165), Ang1 (Ad-Ang1) or enhanced green fluorescence protein (Ad-EGFP) was injected into the ischemic myocardium immediately. Bromodexyuridine (BrdU) was administered intraperitoneally 1 week after ligation. One week later, the hearts were harvested and sectioned for hematoxylin-eosin (HE) and immunohistochemistry to evaluate densities of capillary, arteriole and double labelled BrdU(+) CM. M-mode echocardiography was used to evaluate the cardiac function. Results. Ang1 significantly increased collateral vessel formation. Both VEGF165 and Ang 1 significantly increased densities of capillary and arteriole, as well as the number of double labelled BrdU(+) CM, and improved cardiac function. Conclusion. Our results suggest that the combination of VEGF165 and Ang1 can increase both myocardial angiogenesis and CM proliferation following myocardial ischemia in rats, leading to improved cardiac function.
What problem does this paper attempt to address?